Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & loss statements.

The United States pharmaceutical intermediates market is poised for steady growth, with projections indicating a rise from USD 6,591.4 million in 2025 to USD 9,052.8 million by 2035. This expansion ...

The development is set to make India less reliant on China for imports of raw material used by the pharmaceutical industry.

Pharmaceutical Intermediates Market Scope and Growth BURLINGAME, CA, UNITED STATES, March 13, 2025 /EINPresswire / -- The pharmaceutical inter ...

The China pharmaceutical intermediate market is set for significant expansion, with a projected valuation of USD 9,309.7 million in 2025, growing at a CAGR of 6.4% to reach USD 17,276.3 million by ...

Shortly after WuXi AppTec provided an upbeat outlook for 2025, several other WuXi sibling companies are coming forward with ...

To support the implementation of DPCO, 2013, the Integrated Pharmaceutical Database Management System (IPDMS) was developed.

The Delhi High Court denied Roche's request to temporarily restrain Natco Pharma from producing its spinal muscular atrophy ...

NDV-01 is a novel, sustained-release, intravesical gemcitabine/docetaxel, ready-for-use product candidate for the treatment of non-muscle ...

The United Laboratories International Holdings Limited (OTCMKTS:ULIHF – Get Free Report) was the target of a significant growth in short interest during the month of February. As of February 28th, ...

As Emergent BioSolutions continues to pawn off manufacturing real estate in its pivot from production specialist to full-time ...

India and the US are set to increase market access and improve bilateral trade by reducing tariffs and enhancing supply chain ...